Agilent acquires Stratagene

Friday, 08 June, 2007

Agilent Technologies has announced the acquisition of the company Stratagene, effective as of today.

The takeover is hoped to assist the company in providing more complete workflow solutions in genomics, proteomics and metabolomics.

Stratagene will operate as a division of the company's Life Sciences Solutions unit.

The company has said current customers should expect no change in the way they work with Stratagene and should be able to continue using their existing contact channels.

Related News

Billion-dollar deal for UQ's molecular clamp vaccine tech

Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...

Director of scandal-ridden Forensic Science Queensland resigns

Dr Linzi Wilson-Wilde resigned from her position one month after being suspended by Queensland...

$492m pathology hub coming to Westmead Health Precinct

The NSW Health Pathology Statewide Hub will be delivered to Westmead Health Precinct, as part of...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd